HNF4A and diabetes mellitus: Overall, our work provides a valuable resource of HNF4A and HNF1A targets in human pancreatic and hepatic cells, with a focus on the beta cells which lie at the heart of diabetes pathophysiology, revealing potential therapeutic targets and pathways to guide future strategies for treating diabetes.